Beacon Angels

Chairman William J. Schnoor guides the group's strategic direction, but investment decisions are made by individual members who vote to invest their own capital in deals. A member steering committee manages due-diligence coordination and schedules monthly pitch meetings. Beacon Angels has no central general partner making binding commitments.

Deal flow comes primarily through the extended networks of its 40–60 accredited members, many of whom are current or former operators and executives in the Boston area. Startups apply through the group's website and are screened by a selection committee before being invited to present at the monthly pitch event.

It is neither. Beacon Angels is an angel syndicate — an unincorporated group of individual angel investors who jointly evaluate deals and invest separately. The group charges no management fee and takes no carried interest, which distinguishes it structurally from family offices and professional venture funds.

Beacon Angels pursues only direct investments in operating companies. It does not commit capital to venture or private equity funds, nor does it participate as a limited partner in any known fund structure.

The group targets pre-revenue to Series A companies, typically writing aggregate checks between $250,000 and $1 million per round. Beacon Angels often acts as a company's first institutional investor before dedicated seed or Series A venture funds enter.

The group has historically avoided capital-intensive sectors like biotech, medical devices, and hard-tech manufacturing, concentrating instead on enterprise software, digital health, AI/ML, and cybersecurity opportunities where member expertise and capital efficiency align.

Member wealth originates from diverse sources including executive careers, prior entrepreneurial exits, professional-services practices, and inherited family assets. The group does not disclose individual member net worth or consolidated wealth origins.